{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:28:05Z","timestamp":1752550085839},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2327,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p> <jats:italic>Background<\/jats:italic>: One\u2010week triple regimens are currently the most recommended therapy for the eradication of <jats:italic>Helicobacter pylori<\/jats:italic>. No previous study has evaluated the efficacy of a short\u2010term regimen combining ranitidine bismuth citrate with two antibiotics.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: Seventy\u2010two consecutive <jats:italic>H. pylori<\/jats:italic>\u2010positive dyspeptic patients were recruited for this randomized, three\u2010centre, open, parallel\u2010group study. They were subdivided into two groups receiving either ranitidine bismuth citrate 400\u2003mg b.d.\u2003+\u2003clarithromycin 250\u2003mg b.d. and metronidazole 500\u2003mg b.d. (group A) or ranitidine bismuth citrate 400\u2003mg b.d.\u2003+ clarithromycin 250\u2003mg b.d. and metronidazole 250\u2003mg q.d.s (group B) for 1 week. <jats:italic>H. pylori<\/jats:italic> infection was assessed by CLO\u2010test and histology on both antral and corpus biopsies before and at least 4 weeks after the end of therapy. The bacterium was considered eradicated when both tests were negative. Eradication rates and the number of side\u2010effects were evaluated in each group. The Chi\u2010squared test was used for statistical analysis.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: One patient with only CLO\u2010test positivity was erroneously randomized to group B and four patients dropped out of the study (two in group A and two in group B), mainly because they refused the second endoscopy. In group A, <jats:italic>H. pylori<\/jats:italic> was eradicated in 31 of 36 patients intention\u2010to\u2010treat\u2003=\u200386%; 95% CI\u2003=\u200371\u201395% and (per protocol 31\/34\u2003=\u200391%; 95% CI\u2003=\u200376\u201398%). Side\u2010effects occurred in 10 patients (27%) and they were generally mild. In group B, <jats:italic>H. pylori<\/jats:italic> was eradicated in 29 of 35 patients (intention\u2010to\u2010treat\u2003=\u200383%; 95% CI\u2003=\u200366\u201393%; and per protocol 29\/33\u2003=\u200388%; 95% CI\u2003=\u200372\u201397%). Seven patients (20%) complained of modest side\u2010effects. There was no significant difference between the two treatment arms (<jats:italic>P<\/jats:italic>\u2003=\u2003N.S.); no severe adverse events occurred and none of the patients was withdrawn from the study because of them.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>: The co\u2010administration of ranitidine bismuth citrate plus clarithromycin at low dosage and metronidazole in twice daily doses for 1 week is a short, effective and well\u2010tolerated regimen for the eradication of <jats:italic>H. pylori<\/jats:italic>. These findings should provide the impetus for large\u2010scale investigations.<\/jats:p>","DOI":"10.1046\/j.1365-2036.1997.00202.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T11:43:13Z","timestamp":1068810193000},"page":"699-703","source":"Crossref","is-referenced-by-count":31,"title":["A new 1\u2010week therapy for <i>Helicobacter pylori<\/i> eradication: rani\u2010 tidine bismuth citrate plus two antibiotics"],"prefix":"10.1111","volume":"11","author":[{"given":"V.","family":"SAVARINO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"MANSI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"MELE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"BISSO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. S.","family":"MELA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"SAGGIORO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"CAROLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"VIGNERI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"TERMINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"OLIVIERI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"TOSATTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"CELLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00202.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:17:18Z","timestamp":1694402238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00202.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00202.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00202.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}